Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Symptoms of Schizophrenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00237809
What this trial is testing

D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Yale University 104
Post-approval studies (Phase 4)UnknownNCT02935998
What this trial is testing

The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic Agitation

Who this might be right for
Schizophrenia
Yang Fude 1,000
Not applicableLooking for participantsNCT07091344
What this trial is testing

Cognitive and Metacognitive Evaluation in VR-Based Avatar Therapy for Psychosis

Who this might be right for
Schizophrenia DisordersTreatment Resistant Hallucinations
Fundació Sant Joan de Déu 30
Not applicableLooking for participantsNCT06835556
What this trial is testing

Volatility in Paranoia (VIP) Trial: An RCT of Changes in Volatility With Psychotherapy

Who this might be right for
Schizophrenia Disorders
Vanderbilt University Medical Center 120
Post-approval studies (Phase 4)Study completedNCT02034474
What this trial is testing

Tocilizumab as Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
New York State Psychiatric Institute 59
Early research (Phase 1)Study completedNCT01101659
What this trial is testing

Ketamine Challenge Study With JNJ-40411813

Who this might be right for
Perceptual DisordersConfusionSchizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 40
Not applicableUnknownNCT04399096
What this trial is testing

Sound and Vision: A Collaboration Between Service-users, Artists and the Public to Explore the Lived Experience of Hallucinations

Who this might be right for
SchizophreniaParkinson DiseaseHallucinations
University of Cambridge 500
Post-approval studies (Phase 4)Study completedNCT01399450
What this trial is testing

Paliperidone ER(Invega®) on Depressive Symptoms of Schizophrenia Patients

Who this might be right for
Schizophrenia
Seoul National University Hospital 11
Not applicableStudy completedNCT01386918
What this trial is testing

Repetitive Transcranial Magnetic Stimulation for Refractory Auditory Hallucinations in Schizophrenia

Who this might be right for
Refractory Schizophrenia
Centre for Addiction and Mental Health 144
Not applicableUnknownNCT06207526
What this trial is testing

Delusion Ideation in the Context of Everyday Life

Who this might be right for
Psychotic Disorder
Charite University, Berlin, Germany 15
Large-scale testing (Phase 3)Ended earlyNCT00148590
What this trial is testing

Memantine for the Prevention of Cognitive Dysfunction and Negative Symptoms in Patients With Acute Schizophrenia

Who this might be right for
Schizophrenia
M. Schaefer, MD 24
Not applicableNot Yet RecruitingNCT07788755
What this trial is testing

NEURO-COGS: Neurometabolic Mechanisms of Cognitive Training in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderCognitive Impairment+1 more
University of Minnesota 168
Testing effectiveness (Phase 2)Study completedNCT02525315
What this trial is testing

Interest of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Auditory Hallucinations

Who this might be right for
Schizophrenic Disorders
University Hospital, Caen 15
Testing effectiveness (Phase 2)Study completedNCT00001482
What this trial is testing

New Drugs in the Treatment of Mood Disorders

Who this might be right for
Anxiety DisorderMood DisorderPsychotic Disorder
National Institute of Mental Health (NIMH) 60
Testing effectiveness (Phase 2)Looking for participantsNCT06340789
What this trial is testing

Neurotransmitters in Treatment Resistant Schizophrenia Patients With add-on Sodium Benzoate

Who this might be right for
Symptom, CognitiveSchizophreniaSchizo Affective Disorder
National Cheng-Kung University Hospital 90
Not applicableStudy completedNCT03273439
What this trial is testing

RTMS for Cognitive Deficits in Chronic Patients With Schizophrenia

Who this might be right for
Schizophrenia
Suzhou Psychiatric Hospital 47
Not applicableStudy completedNCT04661163
What this trial is testing

CHALLENGE. A Randomised Clinical Trial Examining Virtual Reality Therapy

Who this might be right for
Auditory Hallucinations
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital 270
Post-approval studies (Phase 4)Study completedNCT00351936
What this trial is testing

A Placebo-Controlled, Cross-Over Trial of Aripiprazole

Who this might be right for
Schizophrenia
North Suffolk Mental Health Association 16
Not applicableUnknownNCT06505564
What this trial is testing

VR-based Avatar Therapy for Treatment of Auditory Hallucinations

Who this might be right for
Hallucinations, AuditorySchizophrenia Spectrum and Other Psychotic Disorders
Semmelweis University 90
Testing effectiveness (Phase 2)Study completedNCT01393600
What this trial is testing

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 37
Next Page